Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis
Authors:
- 24 July 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 35 (6) , 309-316
Abstract
Purpose of review: In patients with systemic sclerosis (SSc), vascular manifestations precede skin and organ fibrosis. There is increasing evidence demonstrating a pathogenic link between early vascular injury and subsequent development of tissue fibrosis. Recent findings: Our knowledge of cellular and molecular mechanisms underlying a unique relationship between SSc-related vasculopathy and fibrosis has changed over the last few years. There is increasing evidence showing viral infection as a potential trigger elucidating vascular injury. Due to defective vascular repair machinery, this initial event results in endothelial cell activation and apoptosis as well as the recruitment of inflammatory/immune cells, leading to endothelial-to-mesenchymal transition. This sequential process induces destructive vasculopathy in capillaries, fibroproliferative vascular lesions in arteries, and excessive fibrosis in the surrounding tissue. A variety of molecular mechanisms and pathways involved in vascular remodeling linked to subsequent excessive fibrosis have been identified and serve as attractive therapeutic targets for SSc. Summary: Endothelial injury may play a central role in connecting three features that characterize SSc pathogenesis: vasculopathy, chronic inflammation, and fibrosis. Our understanding of the processes responsible for myofibroblast differentiation triggered by vascular injury will provide the rationale for novel targeted therapies for SSc.Keywords
This publication has 61 references indexed in Scilit:
- Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic SclerosisNew England Journal of Medicine, 2014
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2013
- The Chemistry and Biology of Soluble Guanylate Cyclase Stimulators and ActivatorsAngewandte Chemie International Edition, 2013
- Review: Evidence That Systemic Sclerosis Is a Vascular DiseaseArthritis & Rheumatism, 2013
- Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β–dependent mesenchymal‐to‐mesenchymal transitionArthritis & Rheumatism, 2012
- Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupAnnals of the Rheumatic Diseases, 2011
- Involvement of functional autoantibodies against vascular receptors in systemic sclerosisAnnals of the Rheumatic Diseases, 2011
- Randomized, prospective, placebo‐controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosisArthritis & Rheumatism, 2010
- Human Parvovirus B19 (B19V) Infection in Systemic Sclerosis PatientsIntervirology, 2009
- Stimulatory Autoantibodies to the PDGF Receptor in Systemic SclerosisNew England Journal of Medicine, 2006